topical ointment stock
PHARMACY

Lupin intros generic Temovate ointment

BY Sandra Levy

Lupin is launching its generic Temovate (clobetasol propionate ointment 0.05%). The product was previously approved by the Food and Drug Administration.

The product is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Clobetasol propionate ointment 0.05% had a market value of approximately $93.4 million, according to June 2018 IQVIA data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

What area is your company focused most on in 2019?
  • Add your answer